A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a japanese population: The takahata study

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Shibata, Yoko ^a   Inoue, Sumito ^a   Igarashi, Akira ^a   Yamauchi, Keiko ^a   Abe, Shuichi ^a   Aida, Yasuko ^a   Nunomiya, Keiko ^a   Sato, Masamichi ^a   Nakano, Hiroshi ^a   Sato, Kento ^a   Nemoto, Takako ^a   Kimura, Tomomi ^a   Watanabe, Tetsu ^a   Konta, Tsuneo ^a   Daimon, Makoto ^a   Ueno, Yoshiyuki ^a   Kato, Takeo ^a   Kayama, Takamasa ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH CERTIFICATE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; JAPANESE; LONGITUDINAL STUDY; LUNG CANCER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROGNOSIS; RESPIRATORY FAILURE; RISK ASSESSMENT; SPIROMETRY; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84892489241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083725     Document Type: Article

References (33)

1. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR et al. (1996) Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 313: 711-716; discussion: 8819439.
2. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P (1990) Spirometric findings and mortality in never-smokers. J Clin Epidemiol 43: 867-873. doi:10.1016/0895-4356(90)90070-6. PubMed: 2213076.
3. Sin DD, Wu L, Man SF (2005) The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127: 1952-1959. doi:10.1378/chest.127.6.1952. PubMed: 15947307.
4. GOLD Global Initiative for Chronic. Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (updated 2011).
5. Fukuchi Y, Nishimura M, Ichinose M, Adachi M, Nagai A et al. (2004) COPD in Japan: the Nippon COPD Epidemiology study. Respirology 9: 458-465. doi:10.1111/j.1440-1843.2004.00637.x. PubMed: 15612956.
6. WHO (2007) World Health. Statistics.
7. Wada H, Nakano Y, Nagao T, Osawa M, Yamada H et al. (2010) Detection and prevalence of chronic obstructive pulmonary disease in a cardiovascular clinic: evaluation using a hand held FEV(1)/FEV(6) meter and questionnaire. Respirology 15: 1252-1258. doi:10.1111/j.1440-1843.2010.01854.x. PubMed: 20920134.
8. Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y et al. (2009) Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 179: 35-40. doi:10.1164/rccm.200804-560OC. PubMed: 18931335.
9. Nagai A (2013) Epidemiology and Socie-economic burden. Tokyo: Medical Review co., ltd. 161 pp.
10. Aida Y, Shibata Y, Osaka D, Abe S, Inoue S et al. (2011) The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study. Int J Med Sci 8: 470-478. PubMed: 21850198.
11. Kishi H, Shibata Y, Osaka D, Abe S, Inoue S et al. (2011) FEV6 and FEV1/FEV6 in Japanese participants of the community-based annual health check: the Takahata study. Intern Med 50: 87-93. doi:10.2169/internalmedicine.50.4276. PubMed: 21245630.
12. Nemoto T, Shibata Y, Osaka D, Abe S, Inoue S et al. (2011) Impact of cigarette smoking on maximal expiratory flows in a general population: the Takahata study. Intern Med 50: 2547-2555. doi:10.2169/internalmedicine.50.5948. PubMed: 22041355.
13. Nunomiya K, Shibata Y, Abe S, Inoue S, Igarashi A et al. (2013) Hyperhomocysteinaemia predicts the decline in pulmonary function in healthy male smokers. Eur Respir J 42: 18-27. doi:10.1183/09031936.00066212. PubMed: 23143543.
14. Osaka D, Shibata Y, Abe S, Inoue S, Tokairin Y et al. (2010) Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: the Takahata study. Intern Med 49: 1489-1499. doi:10.2169/ internalmedicine.49.3364. PubMed: 20686279.
15. Sato M, Shibata Y, Abe S, Inoue S, Igarashi A et al. (2013) Retrospective analysis of the relationship between decline in FEV1 and abdominal circumference in male smokers: The Takahata Study. Int J Med Sci 10: 1-7. doi:10.7150/ijms.5003. PubMed: 23288999.
16. Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S et al. (2011) Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 8: 514-522. PubMed: 21897765.
17. Daimon M, Konta T, Oizumi T, Karasawa S, Kaino W et al. (2012) Higher plasma renin activity is a risk factor for total mortality in older Japanese individuals: the Takahata study. Metabolism 61: 504-511. doi:10.1016/j.metabol. 2011.08.004. PubMed: 22001336.
18. Konta T, Kudo K, Sato H, Ichikawa K, Ikeda A et al. (2013) Albuminuria is an independent predictor of all-cause and cardiovascular mortality in the Japanese population: the Takahata study. Clin Exp Nephrol: ([MedlinePgn:]) PubMed: 23345069.
19. The Committee of Pulmonary Physiology JRS (2004) Guidelines for Pulmonary Function Tests: Spirometry, flow-volume curve, diffusion capacity of the lung. Tokyo: Medical Review Co., Ltd. p. 56.
20. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F et al. (2005) Interpretative strategies for lung function tests. Eur Respir J 26: 948-968. doi:10.1183/09031936.05.00035205. PubMed: 16264058.
21. Steyerberg E (2009) Clinical Prediction Models: A Practical Approach to Development, Validation and Updating. New York: Springer.
22. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O et al. (2011) A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305: 1553-1559. doi:10.1001/jama.2011.451. PubMed: 21482743.
23. Burnham K, Anderson DR (2002) Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach. New York: Springer.
24. Wagenmakers EJ, Farrell S (2004) AIC model selection using Akaike weights. Psychon Bull Rev 11: 192-196. doi:10.3758/BF03206482. PubMed: 15117008.
25. Yamaoka K, Nakagawa T, Uno T (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 6: 165-175. PubMed: 671222.
26. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr., Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-212; discussion: 17569110.
27. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE et al. (2005) The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 142: 233-239. doi:10.7326/0003-4819- 142-4-200502150-00005. PubMed: 15710956.
28. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y et al. (2012) Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185: 44-52. doi:10.1164/rccm. 201106-0992OC. PubMed: 22016444.
29. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD et al. (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11: 122. PubMed: 20831787.
30. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S et al. (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359: 1543-1554. doi:10.1056/NEJMoa0805800. PubMed: 18836213.
31. de Torres JP, Marín JM, Casanova C, Cote C, Carrizo S et al. (2011) Lung cancer in patients with chronic obstructive pulmonary disease - incidence and predicting factors. Am J Respir Crit Care Med 184: 913-919. doi:10.1164/rccm.201103-0430OC. PubMed: 21799072.
32. Cosio MG, Saetta M (2012) Evasion of COPD in smokers: at what price? Eur Respir J 39: 1298-1303. doi:10.1183/09031936.00135711. PubMed: 22005915.
33. Suwabe A (2008) Respiratory diseases (in Japanese). J Jpn Soc Int Med 97: 2927-2935.